Sign in

CIK 0001762303 · Non-accelerated filer<br>Smaller reporting company

AVITA Medical, Inc.

Sign in to watch
Tickers
RCEL AVHHL
Exchange
Nasdaq, OTC
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
202578762
Phone
661-568-1317
Business address
28159 AVENUE STANFORD, SUITE 220, VALENCIA, CA, 91355
Former names
Avita Therapeutics, Inc., Avita Medical, Ltd.

Securities

  • RCEL Common Stock Nasdaq
  • AVHHL Common stock OTC
  1. 4 Grant or award Chief Legal Officer acquired 98,390 shares (grant or award)
  2. 4 Open-market buy Director bought 10,000 shares at $4.50 ($45,000)
  3. 4 Open-market buy CFO bought 2,000 shares at $4.52 ($9,040)
  4. 4 Open-market buy Director bought 10,000 shares at $5.00 ($50,000)
  5. 4 Open-market buy CFO bought 2,000 shares at $4.81 ($9,620)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Grant or award Director acquired 10,022 shares (grant or award)
  8. 4 Grant or award Director acquired 10,022 shares (grant or award)
  9. 4 Grant or award Director acquired 10,022 shares (grant or award)
  10. 4 Grant or award Director acquired 10,022 shares (grant or award)
  11. 4 Grant or award Director acquired 10,022 shares (grant or award)
  12. 4 Grant or award Director acquired 10,022 shares (grant or award)
  13. 4 Derivatives Options or other derivatives
  14. 4 Grant or award CFO acquired 1,923 shares (grant or award)
  15. 4 Open-market buy Director bought 11,000 shares at $8.30 ($91,300)
  16. 4 Open-market buy Director bought 10,000 shares at $10.09 ($100,900)
  17. 4 Open-market buy CFO bought 1,000 shares at $9.90 ($9,900)
  18. 4 Open-market buy CFO bought 1,000 shares at $10.25 ($10,250)
  19. 4 Open-market buy Director bought 486 shares at $13.15 ($6,391)
  20. 4 Derivatives Options or other derivatives

Page 2 of 7 · 140 filings